2-FEA: Difference between revisions
>Unity Added approval header panel. Formatting. |
>Dextromethorphan expanded/removed details |
||
Line 27: | Line 27: | ||
|{{effects/physical| | |{{effects/physical| | ||
*'''[[Effect::Stimulation]]''' - | *'''[[Effect::Stimulation]]''' - 2-FEA has been reported to produce a paradoxical combination of sedating and stimulatory effects, with the sedating aspects believed to be attributable to the believed serotonin it releases. The stimulatory effects are typically more prominent at dosages in and above the strong dosage range and tend to become prominent after the peak effects of a dose have subsided. | ||
*'''[[Effect::Physical euphoria]]''' | *'''[[Effect::Physical euphoria]]''' | ||
*'''[[Effect::Tactile enhancement]]''' | *'''[[Effect::Tactile enhancement]]''' | ||
Line 42: | Line 42: | ||
*'''[[Effect::Increased perspiration]]''' | *'''[[Effect::Increased perspiration]]''' | ||
*'''[[Effect::Nausea]]''' | *'''[[Effect::Nausea]]''' | ||
*'''[[Effect::Pupil dilation]]''' | *'''[[Effect::Pupil dilation]]''' | ||
*'''[[Effect::Teeth grinding]]''' | *'''[[Effect::Teeth grinding]]''' | ||
*'''[[Effect::Temporary erectile dysfunction]]''' | *'''[[Effect::Temporary erectile dysfunction]]''' | ||
*'''[[Effect::Vasoconstriction]]''' | *'''[[Effect::Vasoconstriction]]''' | ||
Line 99: | Line 99: | ||
Anecdotal reports which describe the effects of this compound within our [[experience index]] include: | Anecdotal reports which describe the effects of this compound within our [[experience index]] include: | ||
{{#ask: [[Category:2-FEA]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:2-FEA]][[Category:Experience]]|format=ul|Columns=1}} | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{Further|Research chemicals#Toxicity and harm potential}} | {{Further|Research chemicals#Toxicity and harm potential}} |